21 related articles for article (PubMed ID: 12375054)
1. Clinical significance of P53 and Bcl-2 in acute myeloid leukemia patients of Eastern India.
Sahu G; Jena RK
Hematol Rep; 2011 Oct; 3(3):e28. PubMed ID: 22593819
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targeting of mutated p53 in acute lymphoblastic leukemia.
van Leeuwen FN
Haematologica; 2020 Jan; 105(1):10-11. PubMed ID: 31894096
[No Abstract] [Full Text] [Related]
3. Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia.
Chitadze G; Stengel A; John-Klaua C; Bruckmüller J; Trautmann H; Kotrova M; Darzentas F; Kelm M; Pal K; Darzentas N; Bastian L; Kehden B; Wessels W; Ströh AS; Oberg HH; Altrock PM; Baer C; Meggendorfer M; Gökbuget N; Baldus CD; Haferlach C; Brüggemann M
Blood; 2023 Mar; 141(13):1640-1644. PubMed ID: 36450137
[No Abstract] [Full Text] [Related]
4. The acute lymphoblastic leukemia prognostic scoring whether it is possible by BCL-2, BAX gene promoter genotyping.
Moazami-Goudarzi M; Farshdousti-Hagh M; Hoseinpour-Feizi A; Talebi M; Movassaghpour-Akbari AA; Shams-Asanjan K; Eyvazi-Ziyaee J; Seifi M
Caspian J Intern Med; 2016; 7(2):105-13. PubMed ID: 27386062
[TBL] [Abstract][Full Text] [Related]
5. The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic Leukemias.
Tzifi F; Economopoulou C; Gourgiotis D; Ardavanis A; Papageorgiou S; Scorilas A
Adv Hematol; 2012; 2012():524308. PubMed ID: 21941553
[TBL] [Abstract][Full Text] [Related]
6. Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas: no evidence for prognostic significance.
Hofmockel G; Wittmann A; Dammrich J; Bassukas ID
Anticancer Res; 1996; 16(6B):3807-11. PubMed ID: 9042262
[TBL] [Abstract][Full Text] [Related]
7. Expression of p53 and bcl-2 proteins in acute leukemias: an immunocytochemical study.
Klobusická M; Kusenda J; Babusíkova O
Neoplasma; 2001; 48(6):489-95. PubMed ID: 11949843
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma.
Sohn SK; Jung JT; Kim DH; Kim JG; Kwak EK; Park Ti; Shin DG; Sohn KR; Lee KB
Am J Hematol; 2003 Jun; 73(2):101-7. PubMed ID: 12749011
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S
J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315
[TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2002; 49(6):387-93. PubMed ID: 12584586
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of p53 and Bcl-2 in acute lymphoblastic leukemia.
Sahu GR; Das BR
Oncol Rep; 2002; 9(6):1391-8. PubMed ID: 12375054
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and predictive significance of p53 mutation in aggressive B-cell lymphoma.
Ichikawa A
Int J Hematol; 2000 Apr; 71(3):211-20. PubMed ID: 10846825
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
